Growth response in Turner syndrome with recombinant human growth hormone therapy.
Southeast Asian J Trop Med Public Health
;
1995 ; 26 Suppl 1(): 142-5
Article
Dans Anglais
| IMSEAR
| ID: sea-33106
ABSTRACT
Ten Turner syndrome girls whose mean age was 10.9 +/- 2.7 years were treated with recombinant human growth hormone (rhGH), dose 0.6 U/kg/week. Five of them had classical 45, XO karyotype. The mean height velocity increased from 2.8 +/- 1.3 cm/year before treatment to 6.1 +/- 2.06 cm/year after treatment for a period of 1.4 years. The response of treatment correlated well with pretreatment height velocity (<3 cm/year) but not with karyotype. However, the response has been decreasing and an increased dose after the first year of treatment is recommended.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Tests de la fonction thyroïdienne
/
Facteurs temps
/
Syndrome de Turner
/
Taille
/
Développement osseux
/
Protéines recombinantes
/
Femelle
/
Humains
/
Hémoglobine glyquée
/
Hormone de croissance
Type d'étude:
Étude observationnelle
/
Étude pronostique
langue:
Anglais
Texte intégral:
Southeast Asian J Trop Med Public Health
Année:
1995
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS